[Federal Register Volume 60, Number 110 (Thursday, June 8, 1995)]
[Notices]
[Page 30318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13995]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 5, 1995, Radian 
Corporation, P.O. Box 201088, Mopac Blvd., Austin, Texas 78720, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                           Drug                               Schedule  
------------------------------------------------------------------------
Cathinone (1235)..........................................  I           
Methcathinone (1237)......................................  I           
N-Ethylamphetamine (1475).................................  I           
N,N-Dimethylamphetamine (1480)............................  I           
Aminorex (1585)...........................................  I           
4-Methylaminorex (cis isomer) (1590)......................  I           
Methaqualone (2565).......................................  I           
Lysergic acid diethylamide (7315).........................  I           
Tetrahydrocannabinols (7370)..............................  I           
Mescaline (7381)..........................................  I           
3,4-Methylenedioxyamphetamine (7400)......................  I           
3,4-Methylenedioxy-N-ethylamphetamine (7404)..............  I           
3,4-Methylenedioxymethamphetamine (7405)..................  I           
4-Methoxyamphetamine (7411)...............................  I           
Psilocybin (7437).........................................  I           
Psilocyn (7438)...........................................  I           
Dihydromorphine (9145)....................................  I           
Normorphine (9313)........................................  I           
Acetylemthadol (9601).....................................  I           
Alphacetylmethadol except Levo-Alphacetylmethadol (9603)..  I           
Normethadone (9635).......................................  I           
3-Methylfentanyl (9813)...................................  I           
Amphetamine (1100)........................................  II          
Methamphetamine (1105)....................................  II          
Methylphenidate (1724)....................................  II          
Amobarbital (2125)........................................  II          
Pentobarbital (2270)......................................  II          
Secobarbital (2315).......................................  II          
Phencyclidine (7471)......................................  II          
1-Piperidinocyclohexanecarbonitrile (8603)................  II          
Dihydrocodeine (9120).....................................  II          
Oxycodone (9143)..........................................  II          
Hydromorphone (9150)......................................  II          
Diphenoxylate (9170)......................................  II          
Benzoylecgonine (9180)....................................  II          
Ethylmorphine (9190)......................................  II          
Hydrocodone (9193)........................................  II          
Isomethadone (9226).......................................  II          
Meperidine (9230).........................................  II          
Methadone (9250)..........................................  II          
Methadone-intermediate (9254).............................  II          
Morphine (9300)...........................................  II          
Levo-alphacetylmethadol (9648)............................  II          
Oxymorphone (9652)........................................  II          
Alfentanil (9737).........................................  II          
Sufentanil (9740).........................................  II          
Fentanyl (9801)...........................................  II          
------------------------------------------------------------------------

    The firm plans to manufacture deuterated and non-deuterated 
analytical reference standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. Federal Register Representative (CCR), and 
must be filed no later than July 10, 1995.

    Dated: May 31, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-13995 Filed 6-7-95; 8:45 am]
BILLING CODE 4410-09-M